(NCGA) According to a study released today by Informa’s Agribusiness Consulting Group in tandem with the Biotechnology Innovation Organization, America’s farmers’ access to biotechnology seeds has been impeded by regulatory delays in China, costing the overall U.S. economy both jobs and billions of dollars in economic output. Don Duvall, a farmer from Illinois and Chair of the National Corn Growers Association’s Freedom to Operate Action Team said, “This report further confirms something that we have already known: China’s biotech approval process has functioned in an unpredictable manner that compounds delays and has global ramifications. For American agriculture to achieve its full potential, farmers need access to both the most cutting-edge technologies as well as to international markets.” More timely biotech import approvals would benefit China, as well as ag exporters such as the United States, Argentina and Brazil, by increasing food security and decreasing food prices for Chinese consumers while boosting farmer incomes and allowing for the use of more sustainable farming practices. You can find the full report on the NCGA website.